Lanean...
电离辐射降低NSCLC细胞株T790M突变所致TKI耐药
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), which targets EGFR, plays an important role in non-small cell lung cancer (NSCLC) treatment. Patients with somatic activating mutations in the EGFR gene exhibit significant initial response but eventuall...
Gorde:
| Argitaratua izan da: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
中国肺癌杂志编辑部
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000229/ https://ncbi.nlm.nih.gov/pubmed/26302343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2015.08.02 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|